Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
19.34B | 20.08B | 21.12B | 19.67B | 16.03B | 18.98B | Gross Profit |
5.80B | 6.00B | 6.40B | 6.31B | 4.56B | 6.26B | EBIT |
796.05M | 1.05B | 1.44B | 1.78B | 465.61M | 1.39B | EBITDA |
2.36B | 3.26B | 3.62B | 3.54B | 2.48B | 3.07B | Net Income Common Stockholders |
1.42B | 886.44M | 1.28B | 1.35B | 448.52M | 780.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.87B | 5.54B | 6.84B | 7.16B | 4.92B | 3.10B | Total Assets |
37.16B | 34.77B | 33.87B | 31.61B | 27.52B | 28.22B | Total Debt |
3.37B | 1.50B | 1.44B | 1.28B | 53.13M | 68.50M | Net Debt |
-4.50B | -4.05B | -5.39B | -5.89B | -4.87B | -3.04B | Total Liabilities |
7.98B | 6.34B | 6.47B | 6.07B | 3.85B | 4.47B | Stockholders Equity |
29.18B | 28.43B | 27.40B | 25.54B | 23.67B | 23.75B |
Cash Flow | Free Cash Flow | ||||
0.00 | -1.06B | -466.39M | 1.14B | 1.95B | -744.08M | Operating Cash Flow |
0.00 | 1.43B | 2.22B | 1.91B | 2.74B | 2.24B | Investing Cash Flow |
0.00 | -2.46B | -2.28B | -764.12M | -623.05M | -2.99B | Financing Cash Flow |
0.00 | -548.53M | -500.37M | 881.49M | -259.27M | -468.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
85 Outperform | ¥8.61B | 8.16 | 1.38% | -1.68% | -1.26% | ||
81 Outperform | ¥9.29B | 9.92 | 3.71% | 9.95% | -17.59% | ||
72 Outperform | ¥9.19B | 9.33 | 3.78% | 0.75% | 12.11% | ||
71 Outperform | ¥9.03B | 21.35 | 0.71% | 19.16% | 67.89% | ||
69 Neutral | ¥9.36B | 10.64 | 0.56% | 9.79% | -25.96% | ||
67 Neutral | ¥8.93B | 7.58 | 3.11% | 10.57% | 4.16% | ||
66 Neutral | $4.50B | 12.28 | 5.32% | 248.52% | 4.13% | -12.36% |